The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.
Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions in Europe is expected to foster the growth of the Europe drug delivery systems market. On the other hand, regulatory recalls for drug delivery systems by European manufacturers are likely to create a negative impact on the market growth to an extent.
Products with the innovative technology with more effective benefits is a major requirement in the treatment for various chronic diseases. The advancement and development in the treatment are increasing in the last few years. As the prevalence of chronic diseases is increasing in the European region, the demand for more products with advancements is also boosting up. Hence, over the years, researchers have been carrying out research activities which have resulted in product innovations.
For instance, in July 2018, the Roche received CE mark for its innovative Accu-Chek Solo micropump system. The system is a small tube-free insulin delivery device that offers to their users the choice to bolus directly from the pump. The system is a fully functional handheld that comprises detach and re-attach function of pump without wasting insulin. The Accu-Chek Solo micropump integrates and the Roche’s digital health solutions contributing in a combination to provide more effective and personalized diabetes management to their users. The innovations in the drug delivery systems are thus likely to be a prevalent trend in the global drug delivery systems market over the coming years.
EUROPE DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION
By Route of Administration
By Application
By Distribution Channel
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 343,533.9 Million |
| Market Size by 2027 | US$ 610,320.4 Million |
| CAGR (2019 - 2027) | 6.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Drug Delivery Systems Market is valued at US$ 343,533.9 Million in 2018, it is projected to reach US$ 610,320.4 Million by 2027.
As per our report Europe Drug Delivery Systems Market, the market size is valued at US$ 343,533.9 Million in 2018, projecting it to reach US$ 610,320.4 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.
The Europe Drug Delivery Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Drug Delivery Systems Market report:
The Europe Drug Delivery Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Drug Delivery Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Drug Delivery Systems Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Drug Delivery Systems Market
